More on Covidien (COV +4.3%): FQ3 earnings jumped 47% as acquisitions and new products from its...

|By:, SA News Editor

More on Covidien (COV +4.3%): FQ3 earnings jumped 47% as acquisitions and new products from its medical devices unit continue to drive sales growth and offset anemic performance from its pharmaceuticals group.